NEW YORK, Oct. 11, 2016 /PRNewswire/ -- Owing to the growth in cancer incidences in the US, various technologically advanced therapies are now being introduced in the country. One such advanced technology is the Proton Therapy. Previously, the access to proton therapy is limited for a vast population owing to a low number of proton therapy centers, and barriers to insurance coverage for those procedures. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients. Also, the insurance coverage for proton therapy has been improved. Proton therapy is now covered by Medicare, and nearly all healthcare insurance providers. These services have increased the convenience of patient's in managing high costs of the treatment.
The report, "US Proton Therapy Market Forecast to 2022" covers the current and future analysis of US proton therapy market. Furthermore, analysis of the existing and upcoming proton therapy centers in the US, along with an estimation of the shortage of proton centers in the current and future scenario is also provided, which is intended to help players extract benefits from the largely untapped but lucrative proton therapy market. The report also offers state-wise statistics of potential patients for proton therapy, and the current market penetration.
According to the report, by 2022, the US will have 38 proton therapy centers. Consequently, the market will attain revenue of around US$ 1 Billion by 2022, growing at a CAGR of over 16% during the forecast period (2015-2022).
The report also provides an insight of the drivers, challenges, opportunities and market trends, such as kind of treatment room model, types of proton accelerators being installed, etc., which can have a major influence in shaping the market. The research also portrays the growing trend of investment made for establishing a proton therapy center.
On the competitive front, the report covers a brief analysis of existing and upcoming service providers and equipment vendors in the market along with their existing & planned installations in the US till 2022, thus making the report a must read for consultants and companies planning to enter the market. From an equipment provider's perspective, IBA has the maximum proton accelerators installed in the facilities.
Finally, the report provides an opportunity analysis for new players entering the US proton therapy market. This analysis has been done on the basis of shortage of proton therapy centers in different regions of the country.